The US Food and Drug Administration (FDA) has approved Crysvita (burosumab) as a treatment for a rare form of inherited rickets. It is the first drug therapy approved as a treatment for x-linked hypophosphatemia (XLH) with evidence of bone disease in children over one year of age and adolescents...
Read More... Apr 18, 2018Hereditary Vitamin D Resistant Rickets
This page will soon contain more information about hereditary vitamin D resistant rickets and we continue to add thousands of pages of information about medical conditions, drug classes, and medication.
Simply enter the name of your medication and your zip code using the search function in the menu to find the best prices at pharmacies in your area, or if your medication is listed below, click to view prices at pharmacies near you.
Simply enter the name of your medication and your zip code using the search function in the menu to find the best prices at pharmacies in your area, or if your medication is listed below, click to view prices at pharmacies near you.
Blog Posts Related to Hereditary Vitamin D Resistant Rickets:
Share ModRN Health and Earn Rewards!
Login or Register to Share!
For every friend or family member you refer you will earn 100 Reward Points on their first prescription purchase! Plus you earn Reward Points on every prescription purchase they make with their ModRN Health card.
You may share without logging in or registering, but please note you will not receive any reward points.
Search
Set your Location
Or